🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Palmoplantar Pustulosis

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis NCT07013201Phase 240 sites📍 Fountain Valley📍 Douglasville📍 West Bloomfield LEO Pharma · Tests: Delgocitinib cream, Vehicle cream A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis NCT07270003NA1 site📍 Xi'an Xijing Hospital · Tests: Ivarmacitinib International Rare And Severe Psoriasis Expert Network NCT04359394n/a8 sites📍 München📍 Rome📍 Porto University Hospital, Basel, Switzerland · Tests: biological sampling, Phenotypic description, Photography Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) NCT06231381Phase 22 sites📍 Beijing📍 Shanghai Shanghai Huaota Biopharmaceutical Co., Ltd. · Tests: HB0034, Placebo Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers NCT05994976n/a1 site📍 Montreal Innovaderm Research Inc. · Tests: Blood samples collection, Oral samples collection, Hair samples collection, Skin samples collection (skin tape strip an… Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis NCT07503652Phase 41 site📍 Shenyang First Hospital of China Medical University · Tests: Xeligekimab Injection Picankibart in Palmoplantar Pustulosis NCT07552454NA1 site📍 Xi'an Xijing Hospital · Tests: Picankibart A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis NCT07219420Phase 391 sites📍 Birmingham📍 Fremont📍 Miami UCB Biopharma SRL · Tests: Bimekizumab, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy